Biochemistry, Genetics and Molecular Biology
Antibody Affinity
8%
Apolipoprotein
48%
Apolipoprotein B
100%
Apolipoprotein C3
16%
Apolipoprotein E
15%
Blood Level
13%
Blood Lipids
12%
Blood Plasma
54%
Cholesterol Blood Level
11%
Cholesteryl Ester
14%
Chylomicron
10%
Combined Hyperlipidemia
7%
Diacylglycerol Lipase
18%
Diglyceride
17%
Dyslipidemia
19%
Glucose Level
10%
HDL-Cholesterol
26%
High-Density Lipoprotein
17%
Hyperlipidemia
10%
Hypertriglyceridemia
19%
Insulin Resistance
35%
Iodine-125
9%
Lipid
38%
Lipogenesis
11%
Lipoprotein
89%
Lipoprotein Blood Level
10%
Lipoprotein Metabolism
17%
Lovastatin
8%
Low Density Lipoprotein Cholesterol Level
8%
Low-Density Lipoprotein
53%
Macaca fascicularis
8%
Metabolic Pathway
35%
Microsomal Triglyceride Transfer Protein
13%
N-Acetyltransferase
11%
Normal Human
11%
Oleic Acid
11%
Pancreatic Lipase
11%
Proteasome
13%
Radioactivity
8%
Saturated Fat
8%
Secretion (Process)
75%
Statin
13%
Steady State
10%
Transgenic Mouse
10%
Triacylglycerol Blood Level
28%
Triacylglycerol Level
11%
Triacylglycerol Lipase
11%
Triglyceride
91%
Triglyceride-Rich Lipoprotein
14%
Very Low-Density Lipoprotein
54%
Pharmacology, Toxicology and Pharmaceutical Science
Alirocumab
13%
Anacetrapib
7%
Apolipoprotein
8%
Apolipoprotein B
27%
Apolipoprotein E
13%
Atherosclerosis
8%
Cardiovascular Disease
37%
Cardiovascular Risk
30%
Cholesterol Ester Transfer Protein
8%
Clinical Trial
6%
Combination Therapy
13%
Diabetes Mellitus
25%
Diseases
13%
Dyslipidemia
53%
Ezetimibe
6%
Familial Hypercholesterolemia
9%
Fatty Acid
13%
Fenofibrate
19%
Fibric Acid Derivative
15%
High Density Lipoprotein
10%
High Density Lipoprotein Cholesterol
33%
HIV
5%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
17%
Hypercholesterolemia
7%
Hyperlipidemia
22%
Hypertriglyceridemia
12%
Insulin Resistance
32%
Ischemic Heart Disease
9%
Lipoprotein
84%
Lipoprotein A
11%
Lipoprotein Lipase
11%
Low Density Lipoprotein
35%
Low Density Lipoprotein Cholesterol
36%
Low Density Lipoprotein Receptor
9%
Macaca fascicularis
6%
Metabolic Syndrome X
17%
Mevinolin
7%
Nicotinic Acid
7%
Non Insulin Dependent Diabetes Mellitus
43%
Normal Human
6%
Omega-3 Fatty Acid
7%
Pancreatic Lipase
9%
Pathophysiology
7%
Placebo
21%
Receptor
6%
Rosiglitazone
5%
Simvastatin
9%
Statin (Protein)
19%
Triacylglycerol
78%
Very Low Density Lipoprotein
45%
Medicine and Dentistry
Apolipoprotein B
11%
Atherosclerosis
5%
Cardiovascular Disease
30%
Cardiovascular Risk
12%
Cardiovascular System
10%
Cholesterol Intake
5%
Diabetes
14%
Diabetes Mellitus
14%
Diseases
5%
Dyslipidemia
21%
Familial Hypercholesterolemia
5%
High Density Lipoprotein Cholesterol
16%
High Fat Food
5%
Hyperlipidemia
8%
Hypertriglyceridemia
6%
Insulin Resistance
18%
Ischemic Heart Disease
10%
Lipoprotein
23%
Low Density Lipoprotein Cholesterol
21%
Low-Density Lipoprotein
13%
Maturity Onset Diabetes of the Young
12%
Metabolic Syndrome
6%
Monounsaturated Fatty Acid
7%
Niacin
5%
Oxidoreductase
5%
Pathophysiology
5%
Patient with Diabetes
5%
Patient with Type 2 Diabetes
6%
Placebo
6%
Risk Reduction
6%
Saturated Fatty Acid
9%
Secretion (Process)
7%
Statin
11%
Triacylglycerol
29%
Very Low Density Lipoprotein
9%
